25 January 2021 - The EMA has published a draft agenda for this week's CHMP meeting.

The CHMP is due to issue opinions for the following technologies:

• Bevacizumab
  
• Salmeterol xinafoate with fluticasone propionate
  
• Remimazolam
  
• Dostarlimab
  
• Ofatumumab acetate
  
• Selinexor
  
• Cenobamate
  
• Pemigatinib
  
• Somapacitan
  
• Thiotepa
  
• Icosapent ethyl
  
• COVID-19 Vaccine (ChAdOx1-S [recombinant])
  
• Comirnaty - COVID-19 mRNA vaccine (nucleoside-modified)
  
• COVID-19 Vaccine Moderna – COVID-19 mRNA vaccine (nucleoside-modified)
  

Read CHMP agenda